Abstract
Functional tests used in the catheterization laboratory have emerged as a very important adjunctive tool to coronary angiography that can identify patients with myocardial blood flow impairment.
Fractional Flow Reserve (FFR) measurement is highly recommended for detection of ischemia-related coronary lesion(s) when objective evidence of vessel-related ischemia is not available.
Recently, the much simpler instantaneous wave free ratio (iFR) was proposed as an alternative to FFR without the requirement for administration of vasodilators.
More user-friendly techniques like iFR might further contribute to value-based care in coronary interventions.
Keywords: Cardiac catheterization, coronary angiography, Coronary microcirculation, Fractional Flow Reserve (FFR), Instantaneous wave free ratio (iFR), computer tomography CT- derived fractional flow reserve FFRCT.
Current Pharmaceutical Design
Title:Assessment of Coronary Microcirculation During Cardiac Catheterization
Volume: 24 Issue: 25
Author(s): Sasko Kedev *Ivan Vasilev
Affiliation:
- University Clinic of Cardiology, "University Ss Cyril and Methodius" Skopje,Macedonia, the Former Yugoslav Republic of
Keywords: Cardiac catheterization, coronary angiography, Coronary microcirculation, Fractional Flow Reserve (FFR), Instantaneous wave free ratio (iFR), computer tomography CT- derived fractional flow reserve FFRCT.
Abstract: Functional tests used in the catheterization laboratory have emerged as a very important adjunctive tool to coronary angiography that can identify patients with myocardial blood flow impairment.
Fractional Flow Reserve (FFR) measurement is highly recommended for detection of ischemia-related coronary lesion(s) when objective evidence of vessel-related ischemia is not available.
Recently, the much simpler instantaneous wave free ratio (iFR) was proposed as an alternative to FFR without the requirement for administration of vasodilators.
More user-friendly techniques like iFR might further contribute to value-based care in coronary interventions.
Export Options
About this article
Cite this article as:
Kedev Sasko *, Vasilev Ivan , Assessment of Coronary Microcirculation During Cardiac Catheterization, Current Pharmaceutical Design 2018; 24 (25) . https://dx.doi.org/10.2174/1381612824666180702112018
DOI https://dx.doi.org/10.2174/1381612824666180702112018 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Epigenetic Regulation in Particulate Matter-Mediated Cardiopulmonary Toxicities: A Systems Biology Perspective
Current Pharmacogenomics and Personalized Medicine Coronary Intravascular Ultrasound (IVUS): Contemporary Applications and Bases for the Future
Recent Patents on Medical Imaging It’s Time for An Epigenomics Roadmap of Heart Failure
Current Genomics Long-Term Use of Short- and Long-Acting Nitrates in Stable Angina Pectoris
Current Clinical Pharmacology Roles of Insulin Resistance, Endothelial Dysfunction and Lifestyle Changes in the Development of Cardiovascular Disease in Diabetic Patients
Current Drug Targets Phosphoinositide-3 Kinase Signaling in Cardiac Hypertrophy and Heart Failure
Current Pharmaceutical Design Exploring the Potential of NO-Independent Stimulators and Activators of Soluble Guanylate Cyclase for the Medical Treatment of Erectile Dysfunction
Current Pharmaceutical Design The Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT) Family of Proteins: Transcriptional Modifiers with Multi-Functional Protein Interfaces
Current Molecular Medicine Endothelial Effects of Drugs Designed to Treat Erectile Dysfunction
Current Pharmaceutical Design Emerging Strategies and Agents to Lower Cardiovascular Risk by Increasing High Density Lipoprotein Cholesterol Levels
Current Medicinal Chemistry Intranasal Fluorescent Nanocrystals for Longitudinal <i>In Vivo</i> Evaluation of Cerebral Microlesions
Pharmaceutical Nanotechnology Kawasakis Disease, Acrodynia, and Mercury
Current Medicinal Chemistry Considerations in Understanding the Coronary Blood Flow- Left Ventricular Mass Relationship in Patients with Hypertension
Current Cardiology Reviews Benefits of L-Arginine on Cardiovascular System
Mini-Reviews in Medicinal Chemistry Endothelial Progenitor Cells in Prehypertension
Current Pharmaceutical Design Cryptotanshinone Induces Pro-death Autophagy through JNK Signaling Mediated by Reactive Oxygen Species Generation in Lung Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry The Role of Circadian Rhythms in Fatal Arrhythmias and the Potential Impact of Intervention for Sleep-Disordered Breathing
Current Pharmaceutical Design TNF-α and IL-8 in Acute Stroke and the Modulation of these Cytokines by Antiplatelet Agents
Current Neurovascular Research Pharmacogenomics in Aspirin Intolerance
Current Drug Metabolism Hypoxia and Fetal Heart Development
Current Molecular Medicine